bezisterim
-
Closed A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Bezisterim (NE3107) in Adults With Long COVID (ADDRESS-LC)
Post copied from News from the USA The Department of Defense has "announced the approval of a clinical trial award of up to $13.1 million from the U.S. Department of Defense (DOD) to evaluate Bezisterim (NE3107) for treating neurological symptoms associated with long COVID." The funding is...- RaviHVJ
- Thread
- address-lc bezisterim biovie clinical trial long covid neurological
- Replies: 87
- Forum: Recruitment into current ME/CFS research studies